Sierra Oncology Inc (SRRA) - Pharmaceuticals & Hea
Publicado no e em "Mundo", idioma — English. 5 páginas.
It is also developing SRA141, a small molecule inhibitor of the cell division cycle 7 kinase (Cdc7). The company has presence in the US and Canada. Sierra Oncology is headquartered in Vancouver, British Columbia, Canada. Mais